MAPT and Alzheimer disease: Numerous studies on the amyloid and tau alterations in AD have sped up the development of preventive and therapeutic approaches focused on Aβ and tau; however, this focus may overshadow the significance and opportunities of another promising target, neuroinflammation, which has recently gained attention [15,16,17].